Published in Hum Mol Genet on July 16, 2008
Autosomal dominant polycystic kidney disease: the last 3 years. Kidney Int (2009) 3.66
Impaired Wnt-beta-catenin signaling disrupts adult renal homeostasis and leads to cystic kidney ciliopathy. Nat Med (2009) 1.86
Molecular advances in autosomal dominant polycystic kidney disease. Adv Chronic Kidney Dis (2010) 1.77
Advances in the pathogenesis and treatment of polycystic kidney disease. Curr Opin Nephrol Hypertens (2009) 1.73
T-cell factor/β-catenin activity is suppressed in two different models of autosomal dominant polycystic kidney disease. Kidney Int (2011) 1.69
Vinculin regulates cell-surface E-cadherin expression by binding to beta-catenin. J Cell Sci (2010) 1.60
The cell biology of polycystic kidney disease. J Cell Biol (2010) 1.58
Dynamics of the G protein-coupled vasopressin V2 receptor signaling network revealed by quantitative phosphoproteomics. Mol Cell Proteomics (2011) 1.29
Localization of retinitis pigmentosa 2 to cilia is regulated by Importin beta2. J Cell Sci (2011) 1.28
Polycystic liver diseases: congenital disorders of cholangiocyte signaling. Gastroenterology (2011) 1.26
Induction of Ran GTP drives ciliogenesis. Mol Biol Cell (2011) 1.13
Cystic kidney disease: the role of Wnt signaling. Trends Mol Med (2010) 1.10
The Wnt inhibitory factor 1 (WIF1) is targeted in glioblastoma and has a tumor suppressing function potentially by induction of senescence. Neuro Oncol (2011) 1.10
Tissue-engineered three-dimensional in vitro models for normal and diseased kidney. Tissue Eng Part A (2010) 1.09
Emerging evidence of a link between the polycystins and the mTOR pathways. Pathogenetics (2009) 1.09
Tankyrase is necessary for canonical Wnt signaling during kidney development. Dev Dyn (2010) 1.09
Lessons from in vitro studies and a related intracellular angiotensin II transgenic mouse model. Am J Physiol Regul Integr Comp Physiol (2011) 1.08
Role of the polycytin-primary cilia complex in bone development and mechanosensing. Ann N Y Acad Sci (2010) 1.07
Treatment strategies and clinical trial design in ADPKD. Adv Chronic Kidney Dis (2010) 1.05
Carboxy terminal tail of polycystin-1 regulates localization of TSC2 to repress mTOR. PLoS One (2010) 1.05
Conditional mutation of Pkd2 causes cystogenesis and upregulates beta-catenin. J Am Soc Nephrol (2009) 1.02
Fibrosis and progression of autosomal dominant polycystic kidney disease (ADPKD). Biochim Biophys Acta (2011) 1.01
Identification of a polycystin-1 cleavage product, P100, that regulates store operated Ca entry through interactions with STIM1. PLoS One (2010) 1.01
A polycystin-centric view of cyst formation and disease: the polycystins revisited. Kidney Int (2015) 1.01
Whole-exome sequencing reveals LRP5 mutations and canonical Wnt signaling associated with hepatic cystogenesis. Proc Natl Acad Sci U S A (2014) 1.00
The role of the cilium in normal and abnormal cell cycles: emphasis on renal cystic pathologies. Cell Mol Life Sci (2012) 0.99
Meckel-Gruber syndrome and the role of primary cilia in kidney, skeleton, and central nervous system development. Organogenesis (2013) 0.98
Pkd1 regulates lymphatic vascular morphogenesis during development. Cell Rep (2014) 0.94
The ciliary flow sensor and polycystic kidney disease. Nephrol Dial Transplant (2013) 0.93
c-Met and NF-κB-dependent overexpression of Wnt7a and -7b and Pax2 promotes cystogenesis in polycystic kidney disease. J Am Soc Nephrol (2012) 0.92
The γ-secretase cleavage product of polycystin-1 regulates TCF and CHOP-mediated transcriptional activation through a p300-dependent mechanism. Dev Cell (2011) 0.92
Genetic variation of DKK3 may modify renal disease severity in ADPKD. J Am Soc Nephrol (2010) 0.91
The ciliary protein nephrocystin-4 translocates the canonical Wnt regulator Jade-1 to the nucleus to negatively regulate β-catenin signaling. J Biol Chem (2012) 0.89
WIF1 re-expression in glioblastoma inhibits migration through attenuation of non-canonical WNT signaling by downregulating the lncRNA MALAT1. Oncogene (2015) 0.89
Polycystins and partners: proposed role in mechanosensitivity. J Physiol (2014) 0.89
Calcium-mediated mechanisms of cystic expansion. Biochim Biophys Acta (2010) 0.88
Protein kinase A-dependent pSer(675) -β-catenin, a novel signaling defect in a mouse model of congenital hepatic fibrosis. Hepatology (2013) 0.88
Interactions between β-catenin and the HSlo potassium channel regulates HSlo surface expression. PLoS One (2011) 0.88
Wnt and planar cell polarity signaling in cystic renal disease. Organogenesis (2013) 0.86
Planar cell polarity in kidney development and disease. Organogenesis (2011) 0.85
Detecting the surface localization and cytoplasmic cleavage of membrane-bound proteins. Methods Cell Biol (2009) 0.85
The Ran importin system in cilia trafficking. Organogenesis (2011) 0.83
Kidney: polycystic kidney disease. Wiley Interdiscip Rev Dev Biol (2014) 0.81
Polycystin-1 regulates the stability and ubiquitination of transcription factor Jade-1. Hum Mol Genet (2012) 0.81
Loss of vinculin and membrane-bound β-catenin promotes metastasis and predicts poor prognosis in colorectal cancer. Mol Cancer (2014) 0.81
Expression of a naturally occurring angiotensin AT(1) receptor cleavage fragment elicits caspase-activation and apoptosis. Am J Physiol Cell Physiol (2011) 0.80
Aquaporin-1 retards renal cyst development in polycystic kidney disease by inhibition of Wnt signaling. FASEB J (2015) 0.79
HDAC6 is overexpressed in cystic cholangiocytes and its inhibition reduces cystogenesis. Am J Pathol (2014) 0.78
Polycystins and cellular Ca2+ signaling. Cell Mol Life Sci (2012) 0.78
Role of the Polycystins in Cell Migration, Polarity, and Tissue Morphogenesis. Cells (2015) 0.78
The Roles of Primary cilia in Polycystic Kidney Disease. AIMS Mol Sci (2015) 0.77
Polycystin-1 and Gα12 regulate the cleavage of E-cadherin in kidney epithelial cells. Physiol Genomics (2014) 0.76
Extra sensory perception: the role of Gpr receptors in the kidney. Curr Opin Nephrol Hypertens (2014) 0.76
DH9, a novel PPARγ agonist suppresses the proliferation of ADPKD epithelial cells: An association with an inhibition of β-catenin signaling. Invest New Drugs (2009) 0.76
Effect of PKD1 gene missense mutations on polycystin-1 membrane topogenesis. Biochemistry (2010) 0.75
Regulation of Polycystin-1 Function by Calmodulin Binding. PLoS One (2016) 0.75
Systems biology of polycystic kidney disease: a critical review. Wiley Interdiscip Rev Syst Biol Med (2015) 0.75
Signaling mechanisms implicated in cranial sutures pathophysiology: Craniosynostosis. BBA Clin (2016) 0.75
Chromosomal abnormalities in hepatic cysts point to novel polycystic liver disease genes. Eur J Hum Genet (2016) 0.75
Six2creFrs2α knockout mice are a novel model of renal cystogenesis. Sci Rep (2016) 0.75
Heterotrimeric G protein signaling in polycystic kidney disease. Physiol Genomics (2016) 0.75
Hippo signaling in the kidney: the good and the bad. Am J Physiol Renal Physiol (2016) 0.75
Unsung renal receptors: orphan G-protein-coupled receptors play essential roles in renal development and homeostasis. Acta Physiol (Oxf) (2016) 0.75
VIP17/MAL expression modulates epithelial cyst formation and ciliogenesis. Am J Physiol Cell Physiol (2012) 0.75
WNT and beta-catenin signalling: diseases and therapies. Nat Rev Genet (2004) 10.38
Three-dimensional structure of the armadillo repeat region of beta-catenin. Cell (1997) 7.35
Inversin, the gene product mutated in nephronophthisis type II, functions as a molecular switch between Wnt signaling pathways. Nat Genet (2005) 6.67
Ethidium bromide provides a simple tool for identifying genuine DNA-independent protein associations. Proc Natl Acad Sci U S A (1992) 6.23
Polycystic kidney disease. N Engl J Med (2004) 5.73
Genetics and pathogenesis of polycystic kidney disease. J Am Soc Nephrol (2002) 3.52
Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease. J Am Soc Nephrol (2007) 3.26
Wnt signals are transmitted through N-terminally dephosphorylated beta-catenin. EMBO Rep (2001) 3.02
Polycystin-1, STAT6, and P100 function in a pathway that transduces ciliary mechanosensation and is activated in polycystic kidney disease. Dev Cell (2006) 2.64
Early development of polycystic kidney disease in transgenic mice expressing an activated mutant of the beta-catenin gene. Oncogene (2001) 2.63
The polycystic kidney disease 1 gene product modulates Wnt signaling. J Biol Chem (1999) 2.37
Distinct molecular forms of beta-catenin are targeted to adhesive or transcriptional complexes. J Cell Biol (2004) 2.33
Cyst formation and growth in autosomal dominant polycystic kidney disease. Kidney Int (1987) 2.16
Molecular pathogenesis of ADPKD: the polycystin complex gets complex. Kidney Int (2005) 2.13
Adhesion signaling: how beta-catenin interacts with its partners. Curr Biol (2001) 2.12
Comparison of Pkd1-targeted mutants reveals that loss of polycystin-1 causes cystogenesis and bone defects. Hum Mol Genet (2001) 2.09
Interaction of frizzled related protein (FRP) with Wnt ligands and the frizzled receptor suggests alternative mechanisms for FRP inhibition of Wnt signaling. J Biol Chem (1999) 2.05
Mechanical stimuli induce cleavage and nuclear translocation of the polycystin-1 C terminus. J Clin Invest (2004) 2.00
Dysregulation of cellular proliferation and apoptosis mediates human autosomal dominant polycystic kidney disease (ADPKD). Oncogene (1996) 1.81
Cystic renal neoplasia following conditional inactivation of apc in mouse renal tubular epithelium. J Biol Chem (2004) 1.77
C-myc as an inducer of polycystic kidney disease in transgenic mice. Kidney Int (1991) 1.63
Polycystin-1 activation of c-Jun N-terminal kinase and AP-1 is mediated by heterotrimeric G proteins. J Biol Chem (2002) 1.58
The polycystic kidney disease 1 gene product mediates protein kinase C alpha-dependent and c-Jun N-terminal kinase-dependent activation of the transcription factor AP-1. J Biol Chem (1998) 1.57
The genetics and physiology of polycystic kidney disease. Semin Nephrol (2001) 1.57
Overexpression of PKD1 causes polycystic kidney disease. Mol Cell Biol (2006) 1.47
A "two-hit" model of cystogenesis in autosomal dominant polycystic kidney disease? Trends Mol Med (2001) 1.47
Polycystin-1 induces cell migration by regulating phosphatidylinositol 3-kinase-dependent cytoskeletal rearrangements and GSK3beta-dependent cell cell mechanical adhesion. Mol Biol Cell (2007) 1.47
Pioglitazone improves the phenotype and molecular defects of a targeted Pkd1 mutant. Hum Mol Genet (2002) 1.43
Polycystin-1, the PKD1 gene product, is in a complex containing E-cadherin and the catenins. J Clin Invest (1999) 1.41
A polycystin-1 multiprotein complex is disrupted in polycystic kidney disease cells. Mol Biol Cell (2004) 1.39
Polycystin-1 activates the calcineurin/NFAT (nuclear factor of activated T-cells) signaling pathway. J Biol Chem (2004) 1.26
Retracted Beta-catenin N- and C-terminal tails modulate the coordinated binding of adherens junction proteins to beta-catenin. J Biol Chem (2002) 1.16
beta-Catenin and plakoglobin N- and C-tails determine ligand specificity. J Biol Chem (2004) 1.13
Elevated c-myc protooncogene expression in autosomal recessive polycystic kidney disease. Proc Natl Acad Sci U S A (1987) 1.12
The polycystin 1-C-terminal fragment stimulates ERK-dependent spreading of renal epithelial cells. J Biol Chem (2006) 1.05
Aberrant polycystin-1 expression results in modification of activator protein-1 activity, whereas Wnt signaling remains unaffected. J Biol Chem (2004) 1.00
New insights into ADPKD molecular pathways using combination of SAGE and microarray technologies. Genomics (2004) 0.99
Nuclear localization of beta-catenin and loss of apical brush border actin in cystic tubules of bcl-2 -/- mice. Am J Physiol (1999) 0.91
Localization of overexpressed c-myc mRNA in polycystic kidneys of the cpk mouse. Kidney Int (1992) 0.91
Recent advances in the cell biology of polycystic kidney disease. Int Rev Cytol (2003) 0.88
Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature (2002) 5.02
Exosome release of β-catenin: a novel mechanism that antagonizes Wnt signaling. J Cell Biol (2010) 2.85
Mitochondrial reactive oxygen species promote epidermal differentiation and hair follicle development. Sci Signal (2013) 2.78
Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects. Science (2004) 2.39
Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation. Proc Natl Acad Sci U S A (2013) 2.10
Mechanical stimuli induce cleavage and nuclear translocation of the polycystin-1 C terminus. J Clin Invest (2004) 2.00
AMP-activated protein kinase regulates the assembly of epithelial tight junctions. Proc Natl Acad Sci U S A (2006) 1.98
Functional expression of the olfactory signaling system in the kidney. Proc Natl Acad Sci U S A (2009) 1.90
Phospho-regulation of Beta-catenin adhesion and signaling functions. Physiology (Bethesda) (2007) 1.89
Polycystin-1 and polycystin-2 regulate the cell cycle through the helix-loop-helix inhibitor Id2. Nat Cell Biol (2005) 1.88
The uptake and intracellular fate of PLGA nanoparticles in epithelial cells. Biomaterials (2009) 1.82
How megalin finds its way: identification of a novel apical sorting motif. Focus on "Identification of an apical sorting determinant in the cytoplasmic tail of megalin". Am J Physiol Cell Physiol (2003) 1.78
Molecular components of the adherens junction. Biochim Biophys Acta (2008) 1.78
GLI3-dependent transcriptional repression of Gli1, Gli2 and kidney patterning genes disrupts renal morphogenesis. Development (2006) 1.76
Calcium-pump inhibitors induce functional surface expression of Delta F508-CFTR protein in cystic fibrosis epithelial cells. Nat Med (2002) 1.75
Canonical WNT/beta-catenin signaling is required for ureteric branching. Dev Biol (2008) 1.75
ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption. J Clin Invest (2013) 1.74
Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy. Vaccine (2009) 1.72
Presence of de novo mutations in autosomal dominant polycystic kidney disease patients without family history. Am J Kidney Dis (2008) 1.71
Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis. Proc Natl Acad Sci U S A (2011) 1.69
Vesicoureteral reflux in infants with isolated antenatal hydronephrosis. Pediatr Nephrol (2003) 1.69
Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy. Nat Med (2013) 1.62
Wnt coreceptor Lrp5 is a driver of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2014) 1.61
The cell biology of polycystic kidney disease. J Cell Biol (2010) 1.58
Activity of the beta-catenin phosphodestruction complex at cell-cell contacts is enhanced by cadherin-based adhesion. J Cell Biol (2009) 1.57
Familial clustering of medullary sponge kidney is autosomal dominant with reduced penetrance and variable expressivity. Kidney Int (2012) 1.52
β-catenin causes renal dysplasia via upregulation of Tgfβ2 and Dkk1. J Am Soc Nephrol (2011) 1.52
Canonical Wnt signaling induces skin fibrosis and subcutaneous lipoatrophy: a novel mouse model for scleroderma? Arthritis Rheum (2011) 1.51
Systems biology of autosomal dominant polycystic kidney disease (ADPKD): computational identification of gene expression pathways and integrated regulatory networks. Hum Mol Genet (2009) 1.49
Genotype-renal function correlation in type 2 autosomal dominant polycystic kidney disease. J Am Soc Nephrol (2003) 1.48
Association of mutation position in polycystic kidney disease 1 (PKD1) gene and development of a vascular phenotype. Lancet (2003) 1.47
The aquaporin-2 water channel in autosomal dominant primary nocturnal enuresis. J Urol (2002) 1.46
A tricontinental view of IgA nephropathy. Nephrol Dial Transplant (2003) 1.46
Regulation of Wnt/beta-catenin signaling by protein kinases. Dev Dyn (2010) 1.45
Nuclear β-catenin is increased in systemic sclerosis pulmonary fibrosis and promotes lung fibroblast migration and proliferation. Am J Respir Cell Mol Biol (2011) 1.44
Outcome of isolated antenatal hydronephrosis: a systematic review and meta-analysis. Pediatr Nephrol (2005) 1.43
PKHD1 protein encoded by the gene for autosomal recessive polycystic kidney disease associates with basal bodies and primary cilia in renal epithelial cells. Proc Natl Acad Sci U S A (2004) 1.42
β-catenin signaling: a novel mediator of fibrosis and potential therapeutic target. Curr Opin Rheumatol (2011) 1.41
Polycystin-1 distribution is modulated by polycystin-2 expression in mammalian cells. J Biol Chem (2003) 1.38
Genome-wide linkage scan of a large family with IgA nephropathy localizes a novel susceptibility locus to chromosome 2q36. J Am Soc Nephrol (2007) 1.36
Smad1, beta-catenin and Tcf4 associate in a molecular complex with the Myc promoter in dysplastic renal tissue and cooperate to control Myc transcription. Development (2004) 1.36
Beta-catenin/T-cell factor signaling is activated during lung injury and promotes the survival and migration of alveolar epithelial cells. J Biol Chem (2009) 1.35
Macrophages promote cyst growth in polycystic kidney disease. J Am Soc Nephrol (2011) 1.34
Progressive loss of renal function is an age-dependent heritable trait in type 1 autosomal dominant polycystic kidney disease. J Am Soc Nephrol (2005) 1.32
Tubulointerstitial nephritis as an extraintestinal manifestation of Crohn's disease. Nat Clin Pract Nephrol (2008) 1.32
Cell and molecular biology of kidney development. Semin Nephrol (2009) 1.32
Membrane proteins follow multiple pathways to the basolateral cell surface in polarized epithelial cells. J Cell Biol (2009) 1.31
Evaluating the clinical utility of a molecular genetic test for polycystic kidney disease. Mol Genet Metab (2007) 1.31
Preactivation of AMPK by metformin may ameliorate the epithelial cell damage caused by renal ischemia. Am J Physiol Renal Physiol (2011) 1.25
Transport protein trafficking in polarized cells. Annu Rev Cell Dev Biol (2003) 1.24
Shh controls epithelial proliferation via independent pathways that converge on N-Myc. Dev Cell (2005) 1.24
Family history of renal disease severity predicts the mutated gene in ADPKD. J Am Soc Nephrol (2009) 1.23
Wnt/β-catenin signaling is hyperactivated in systemic sclerosis and induces Smad-dependent fibrotic responses in mesenchymal cells. Arthritis Rheum (2012) 1.22
Mice overexpressing BAFF develop a commensal flora-dependent, IgA-associated nephropathy. J Clin Invest (2011) 1.22
Functional analysis of a novel GATA3 mutation in a family with the hypoparathyroidism, deafness, and renal dysplasia syndrome. J Clin Endocrinol Metab (2005) 1.22
Polycystin-2 and phosphodiesterase 4C are components of a ciliary A-kinase anchoring protein complex that is disrupted in cystic kidney diseases. Proc Natl Acad Sci U S A (2011) 1.18
α-catenin cytomechanics--role in cadherin-dependent adhesion and mechanotransduction. J Cell Sci (2014) 1.17
Incident renal events and risk factors in autosomal dominant polycystic kidney disease: a population and family-based cohort followed for 22 years. Clin J Am Soc Nephrol (2006) 1.15
MAL decreases the internalization of the aquaporin-2 water channel. Proc Natl Acad Sci U S A (2007) 1.14
Beta-catenin phosphorylated at serine 45 is spatially uncoupled from beta-catenin phosphorylated in the GSK3 domain: implications for signaling. PLoS One (2010) 1.14
BMP receptor ALK3 controls collecting system development. J Am Soc Nephrol (2008) 1.14
Prospects for mTOR inhibitor use in patients with polycystic kidney disease and hamartomatous diseases. Clin J Am Soc Nephrol (2010) 1.12
Aquaporin-2: COOH terminus is necessary but not sufficient for routing to the apical membrane. Am J Physiol Renal Physiol (2002) 1.12
The tetraspanin CD63 enhances the internalization of the H,K-ATPase beta-subunit. Proc Natl Acad Sci U S A (2003) 1.11
Performance of a career development and compensation program at an academic health science center. Pediatrics (2007) 1.11
A novel gene encoding a TIG multiple domain protein is a positional candidate for autosomal recessive polycystic kidney disease. Genomics (2002) 1.11
p38MAPK acts in the BMP7-dependent stimulatory pathway during epithelial cell morphogenesis and is regulated by Smad1. J Biol Chem (2004) 1.09
TLR9-targeted biodegradable nanoparticles as immunization vectors protect against West Nile encephalitis. J Immunol (2010) 1.09
VE-cadherin and beta-catenin binding dynamics during histamine-induced endothelial hyperpermeability. Am J Physiol Cell Physiol (2008) 1.09
GLI3 repressor controls nephron number via regulation of Wnt11 and Ret in ureteric tip cells. PLoS One (2009) 1.09
Integrin regulation of beta-catenin signaling in ovarian carcinoma. J Biol Chem (2011) 1.06
GLI3 repressor controls functional development of the mouse ureter. J Clin Invest (2011) 1.05
Signal transducer and activator of transcription-6 (STAT6) inhibition suppresses renal cyst growth in polycystic kidney disease. Proc Natl Acad Sci U S A (2011) 1.05
Elevated SMAD1/beta-catenin molecular complexes and renal medullary cystic dysplasia in ALK3 transgenic mice. Development (2003) 1.05
TRPC4 forms store-operated Ca2+ channels in mouse mesangial cells. Am J Physiol Cell Physiol (2004) 1.05
Antigen-specific, antibody-coated, exosome-like nanovesicles deliver suppressor T-cell microRNA-150 to effector T cells to inhibit contact sensitivity. J Allergy Clin Immunol (2013) 1.04
Nesprin-2 interacts with {alpha}-catenin and regulates Wnt signaling at the nuclear envelope. J Biol Chem (2010) 1.04
AMP-activated protein kinase (AMPK) activation and glycogen synthase kinase-3β (GSK-3β) inhibition induce Ca2+-independent deposition of tight junction components at the plasma membrane. J Biol Chem (2011) 1.03
Polycystin-2 regulates proliferation and branching morphogenesis in kidney epithelial cells. J Biol Chem (2005) 1.03
Polycystic kidney disease: pathogenesis and potential therapies. Biochim Biophys Acta (2010) 1.02
Analysis of PKD1 for genomic deletion by multiplex ligation-dependent probe assay: absence of hot spots. Genomics (2007) 1.02
Integrin-linked kinase mediates bone morphogenetic protein 7-dependent renal epithelial cell morphogenesis. Mol Cell Biol (2005) 1.02
Control of murine kidney development by sonic hedgehog and its GLI effectors. Cell Cycle (2006) 1.01
Neonatal renal venous thrombosis: clinical outcomes and prevalence of prothrombotic disorders. J Pediatr (2005) 1.00
Ureteric morphogenesis requires Fgfr1 and Fgfr2/Frs2α signaling in the metanephric mesenchyme. J Am Soc Nephrol (2012) 0.99
Partial correction of cystic fibrosis defects with PLGA nanoparticles encapsulating curcumin. Mol Pharm (2010) 0.99
Bone morphogenetic protein signaling in the developing kidney: present and future. Differentiation (2008) 0.99
The molecular control of renal branching morphogenesis: current knowledge and emerging insights. Differentiation (2002) 0.99
Analysis of published PKD1 gene sequence variants. Nat Genet (2007) 0.98
Paracrine activation of WNT/β-catenin pathway in uterine leiomyoma stem cells promotes tumor growth. Proc Natl Acad Sci U S A (2013) 0.98
Genetics of renal hypoplasia: insights into the mechanisms controlling nephron endowment. Pediatr Res (2010) 0.98